Pituitary adenomas: new insights, new therapeutic targets

Nicholas A Tritos^{1

2}

Affiliations

¹ Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA, USA. ntritos@mgh.harvard.edu.
² Harvard Medical School, Boston, MA, USA. ntritos@mgh.harvard.edu.

Comment

Nicholas A Tritos. Cell Res. 2023 Jan.

. 2023 Jan;33(1):3-4.

doi: 10.1038/s41422-022-00758-z.

Nicholas A Tritos^{1

2}

¹ Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA, USA. ntritos@mgh.harvard.edu.
² Harvard Medical School, Boston, MA, USA. ntritos@mgh.harvard.edu.

No abstract available

Comment on

Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors.
Zhang F, Zhang Q, Zhu J, Yao B, Ma C, Qiao N, He S, Ye Z, Wang Y, Han R, Feng J, Wang Y, Qin Z, Ma Z, Li K, Zhang Y, Tian S, Chen Z, Tan S, Wu Y, Ran P, Wang Y, Ding C, Zhao Y. Zhang F, et al. Cell Res. 2022 Dec;32(12):1047-1067. doi: 10.1038/s41422-022-00736-5. Epub 2022 Oct 28. Cell Res. 2022. PMID: 36307579 Free PMC article.

1. Vandeva S, Daly AF, Petrossians P, Zacharieva S, Beckers A. Eur. J. Endocrinol. 2019;181:R235–R254. doi: 10.1530/EJE-19-0602. - DOI - PubMed
1. Melmed S, et al. Endocr. Rev. 2022;43:1003–1037. doi: 10.1210/endrev/bnac010. - DOI - PMC - PubMed
1. Cano DA, Soto-Moreno A, Leal-Cerro A. Front. Oncol. 2014;4:203. doi: 10.3389/fonc.2014.00203. - DOI - PMC - PubMed
1. Srirangam Nadhamuni V, Korbonits M. Endocr. Rev. 2020;41:821–846. doi: 10.1210/endrev/bnaa006. - DOI - PMC - PubMed
1. Bi WL, et al. Clin. Cancer Res. 2017;23:1841–1851. doi: 10.1158/1078-0432.CCR-16-0790. - DOI - PMC - PubMed